Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ · Manufacturing · Pharmaceutical preparations
$8.75−$0.2900 (−3.21%) on the dayAs of the close; data may be delayed.
OLMA price, last 12 months
Key stats
- Previous close
- $9.04
- Open
- $9.04
- Day range
- $8.57 – $9.04
- 52-week range
- $6.65 – $36.26
- Volume
- 1.2M
- Avg volume (20 days)
- 1.2M
- Market cap
- $765.6M
Performance
1W−10.9%
1M−19.4%
3M−23.2%
6M−38.0%
YTD−65.0%
1Y+4.8%
vs S&P 500, 1Y−12.0 pts
Technicals and fundamentals
About Olema Pharmaceuticals, Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $765.6M